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We prospectively compared sequential portal-arterial revascularization (SPAr, group 1 no. 19) versus contemporaneous portal-
hepatic artery revascularization (CPAr, group 2 no. 21) in 40 consecutive liver transplantation (LT). There were no diﬀerences in
the demographics characteristics, MELD score, indication to LT, and donor’s parameters between the two groups. CPAr had longer
warm ischemia 66 ± 8v e r s u s3 7± 7 min (P<. 001), while SPAr had longer arterial ischemia 103 ± 42min (P = .0004). One-year
patient’s and graft survival were, respectively, 89% and 95% versus 94% and 100% (P = .29). At median followup of 13 ±6v e r s u s
14 ± 7 months biliary complications were anastomotic stenosis in 15% versus 19% (P = .78), and intrahepatic nonanastomotic
biliary strictures in 26% versus none (P = .01), respectively, in SPAr and CPAr. CPAr reduces the incidence of intrahepatic biliary
strictures by decreasing the duration of arterial ischemia.
1.Introduction
Sequential portal-arterial revascularization (SPAr) of the
graft is the most common technique in liver transplantation
(LT), based on the experience that portal blood ﬂow is
suﬃcient for adequate liver function [1, 2]. The main
disadvantage of SPAr might be an increased risk of warm
ischemic damage to the bile ducts, which depend solely on
arterial blood supply [3]. Some authors have advocated the
use of contemporaneous portal-hepatic artery revascular-
ization (CPAr) reporting no diﬀerent parameters of early
graft function, with less intrahepatic nonanastomotic biliary
damages [1, 4]. In our study we prospectively compared
SPAr versus CPAr in terms of graft function, reperfu-
sion syndrome, vascular complications, one-year patient’s
and graft survival, and biliary complications analyzed as
pureanastomotic versus intrahepatic nonanastomotic biliary
strictures.
2. Patientsand Methods
From June 2008 to December 2009, 40 consecutive LT
from heart-beating donors were randomized 1:1 to SPAr
(group 1, no. 19) or CPAr (group 2, no. 21). No diﬀerences
between the groups for indications to OLT have been
evidenced during statistical analysis. Cases requiring an
aortohepatic bypass for arterial revascularization, and reOLT
were excluded from the analysis. The LT was always carried
out by piggy-back technique in all cases. The bile duct
was reconstructed in all cases by termino-terminal duct
to duct anastomosis; the T-tube was used, respectively,
in 32% versus 29% of cases (P = .83). All grafts were
whole liver except one extended right liver split including
segment one in group 1. Portal vein and arterial anas-
tomosis between the graft and the recipient have been
alwaysperformedwithterminal-terminalinterruptedsuture.
In the SPAr group the graft was revascularized through
the portal vein, and the hepatic artery was subsequently
performed; the time interval between portal and arte-
rial revascularization was recorded and deﬁned as arterial
ischemic time. In the CPAr the graft was revascularized
simultaneously through the portal vein, and hepatic artery.
Cold and warm ischemia time were determined, respec-
tively, as the period between cross-clamp and graft inside
the abdomen and between the graft in the abdomen
and reperfusion. Reperfusion syndrome was deﬁned as a
drop in mean arterial pressure greater than 30% within
1 minute from reperfusion of the graft and lasting more2 Journal of Transplantation
Table 1
Group 1 Group 2 P
Duration of surgery 392 ±115 373 ±60 .52
Cold ischemia time 478 ±147 441 ±88 .32
Warm ischemia time 37 ±76 6 ±8 <.0001
Units of blood transfused 6 ±47 ±4. 6 0
Plasma transfused (ml) 1300 ±1175 2382 ±1853 .045
Postreperfusion syndrome 2 5 .26
ICU stay (day) 7 ±45 ±2. 1 2
Total hospital stay (day) 17 ±51 8 ±6. 6 8
Biopsy-proven acute rejection 2 1 .48
Portal complications 0 0 n.a
Arterial complications (thrombosis) 1 0 .76
Biliary complications 9 4 .05
PNF 0 0 n.a.
DGF 4 2 .91
One-year graft survival 18 21 .29
One-year patient survival 17 20 .53
Followup (months) 13 ±61 4 ±7. 7 1
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than 5 minutes. Primary nonfunction (PNF) was deﬁned
as the need for retransplantation or death due to graft
failure within 7 days in absence of technical problems.
Delayed graft function (DGF) was deﬁned as AST or ALT
peak greater than 2000U/ml within 72 hours from LT.
Biliary complications were analyzed when clinically evident
or through magnetic resonance cholangiopancreatography
(MRCP) every 6 months after transplantation in asymp-
tomatic patients.
The type of reperfusion during evaluation of MRCP
of the biliary tree was unknown to the radiologist. More-
over radiologists and gastroenterologists were also blinded
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regarding any diﬀerences in graft reperfusion, during treat-
ment of symptomatic stenosis.
Statistical analysis was performed by the student’s t-test
orchi-squaretestasappropriated.AP valuelessthan .05was
considered signiﬁcant.
3. Results
Recipient’s age and male gender were, respectively, 52 ± 9
versus 56 ± 9( P = .15) years old and 74% versus 75%
(P = .93) in group 1 and 2. No diﬀerences in the indication
for LT were encountered with HCC as the main indicationJournal of Transplantation 3
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in 32% versus 42%, HCV in 26% versus 24%, and alcohol
in 16% versus 19% (P = ns). The MELD score was 17 ± 7
versus 14 ± 5 (0.12). Donor’s age was, respectively, 52 ± 18
versus 51±15 years old in groups 1 and 2 (P = .85). Twenty-
one percent of the grafts in groups 1 versus 19% in group
2 had macrovacuolar steatosis greater than 15% (P = .92).
Duration of LT was not diﬀerent between groups 1 and 2
(392 ± 115 versus 373 ± 60min, P = .52) as well as cold
ischemia time (478 ± 147 versus 441 ± 88min, P = .32),
while warm ischemia time was statistically signiﬁcant longer
in the CPAr group (37 ± 7v e r s u s6 6± 8min, P<. 001).
Arterial ischemic time in the SPAr group was statistically
signiﬁcant longer than warm ischemia time in the CPAr
group (103 ± 42 versus 66 ± 8min, P = .0004). Units of
blood and amount of plasma transfusion were, respectively,
6 ± 4v e r s u s7± 4( P = .60) and 1,300 ± 1,175ml versus
2,382 ± 1,853ml (P = .045) in groups 1 and 2. There were
no PNF in both groups; DGF was diagnosed in 10% versus
9% in groups 1 and 2 (P = .91). ICU and total hospital stay
were, respectively, 7±4v e r s u s5±2a n d1 7±5v e r s u s1 8±6
days, respectively, in groups 1 and 2 (P = .12 and P = .68)
(Table 1). AST and ALT (Figure 1), total bilirubin, INR, GGT
and ALP (Figures 2, 3,a n d4), at days +1, +3, +7, +15,
+30 and +90, did not evidenced any statistically signiﬁcant
diﬀerence between SPAr and CPAr. Vascular complications
were absent except for one case of hepatic artery thrombosis
in group 1 leading to retransplantation. One-year graft and
patient’s survival were, respectively, 95% versus 100% and
89% versus 94% in groups 1 and 2 (P = .29 and P = .53). At
a median follow-up of 13±6v e r s u s1 4±7 months (P = .71)
biliarycomplicationsdiagnosedwereanastomoticstenosisin
15%versus19%(P = .78),andintrahepaticnonanastomotic
biliary strictures in 26% versus none (P = .01), respectively,
in SPAr and CPAr.
In all cases biliary stenosis occurred within 1 year after
OLT,andtheseweresuccessfullytreatedthroughERCPwhen
anastomotic (7 cases, 3 out of groups 1 and 4 out of group 2)
and through PTC (5 cases out of group 1) when intrahepatic
nonanastomotic strictures have been diagnosed.
4. Discussion
The most commonly used procedure for revascularization
of the liver graft is initial reperfusion via the portal vein
and subsequent reconstruction of the hepatic artery [5–
7] .T h ed i s a d v a n t a g ei st h a tp o r t a lv e n o u sb l o o da l o n e
in a progressively rewarming graft may induce ischemic
damage to the biliary tract, which depends solely on the
hepatic artery blood supply. CPAr in LT has theoretically
some potential advantages on SPAr: (a) the liver receives a
larger blood supply during the critical phase of reperfusion
injury; (b) arterial warm ischemia of the graft biliary tree
is reduced; and (c) arterial anastomosis is performed in
a surgical ﬁeld without hemorrhage. The disadvantage of
CPAr is longer warm ischemia time and the anhepatic phase,
which can be detrimental to postoperative graft function,
survival, and morbidity [8, 9]. In our study, recovery of
graft function, and patient and graft survival rates was
similar in both groups. Similar results were reported in two
previous clinical studies that compared CPAr and SPAr with
regard to diﬀerent parameters of early graft function [6–
8]. A delay in reestablishing arterial inﬂow in an exclusively
portal perfused liver potentially prolongs the warm ischemia
time to the bile ducts contributing to the development of
biliary strictures. Non-anastomotic biliary stenosis has been
associated with hepatic artery thrombosis or stenosis and
with prolonged cold and warm ischemia time [10, 11].
Even if a longer warm ischemia time can be a possible risk
factor for biliary strictures [8], it has not been evidenced in
our cases. In our study the arterial warm ischemia time in
the control group (SPAr) was statistically signiﬁcant longer
than warm ischemia time in the CPAr group conﬁrming4 Journal of Transplantation
a possible greater amount of selective arterial ischemia to
the bile duct in the group with sequential portal and arterial
revascularization. This resulted in a higher incidence of
nonanastomotic intrahepatic biliary strictures in the SPAr
group (26% versus none) thereby suggesting a possible
protective role of CPAr on the integrity of the intrahepatic
biliary tree potentially due to less selective arterial ischemia.
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